RIGEL PHARMACEUTICALS INC short interest in 2023
In 2023, RIGEL PHARMACEUTICALS INC's disclosed short interest ran from 3.26% of shares outstanding on 13 Jan 2023 to 2.07% on 29 Dec 2023, a change of -1.19 percentage points. The year's high was 4.90% on 14 Apr 2023 and its low 2.06% on 15 Sep 2023, averaging 3.14% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.68 days on 15 Nov 2023. Full history: RIGEL PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 3.26% (13 Jan 2023)
- End of year
- 2.07% (29 Dec 2023)
- Change
- -1.19 pp
- High
- 4.90% (14 Apr 2023)
- Low
- 2.06% (15 Sep 2023)
- Average
- 3.14%
- Highest days to cover
- 6.68 (15 Nov 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 3.26% | 1.75 | results (8-K) |
| 31 Jan 2023 | 3.46% | 2.04 | |
| 15 Feb 2023 | 3.94% | 3.22 | |
| 28 Feb 2023 | 4.43% | 3.28 | |
| 15 Mar 2023 | 4.88% | 1.41 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 4.82% | 3.11 | |
| 14 Apr 2023 | 4.90% | 4.84 | |
| 28 Apr 2023 | 4.90% | 6.28 | |
| 15 May 2023 | 4.66% | 5.27 | 10-Q filed, results (8-K) |
| 31 May 2023 | 4.33% | 1.54 | |
| 15 Jun 2023 | 3.66% | 3.89 | |
| 30 Jun 2023 | 2.21% | 1.94 | |
| 14 Jul 2023 | 2.22% | 3.16 | |
| 31 Jul 2023 | 2.31% | 3.41 | |
| 15 Aug 2023 | 2.13% | 3.14 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 2.19% | 4.14 | |
| 15 Sep 2023 | 2.06% | 3.81 | |
| 29 Sep 2023 | 2.13% | 4.54 | |
| 13 Oct 2023 | 2.17% | 4.62 | |
| 31 Oct 2023 | 2.08% | 2.01 | |
| 15 Nov 2023 | 2.19% | 6.68 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 2.17% | 1.86 | |
| 15 Dec 2023 | 2.08% | 3.91 | |
| 29 Dec 2023 | 2.07% | 3.92 |
See also: RIGEL PHARMACEUTICALS INC's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.